Data further provide a good platform but requirecareful interpretations, during translation studies for AD therapeutics, given the complexity of AD etiology and should integratemulti-omics data sources to elucidate the interrelations between protein pathways underlying the amyloid, tau, mitochondrial dysfunction,and neuroinflammation hypotheses implicated in disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.